Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Amdocs Sees Q3 GAAP EPS $1.30-$1.38 vs $1.57 Est

Author: Benzinga Newsdesk | May 07, 2025 04:08pm
Amdocs (NASDAQ:DOX) is looking for Q3 GAAP EPS of $1.30-$1.38 vs $1.57 analyst estimate..

Posted In: DOX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist